PE: What policy incentives are created by FDA's ANDA Prioritization Pilot? Botha: Right now, we’re seeing multiple efforts ...

The GCC is becoming a strategic anchor for global venture capital, with Riyadh emerging as a key fundraising hub. Sovereign ...

HHS Secretary Kennedy stated there is insufficient evidence to link Tylenol to autism, conflicting with the Texas lawsuit.

Novartis will acquire Avidity Biosciences in a newly announced definitive merger agreement. The news follows the separation ...

In today’s Pharmaceutical Executive Daily, we cover Thermo Fisher’s $8 billion agreement to acquire Clario Holdings, Eli ...

GSK is set to acquire the exclusive rights for Syndivia’s preclinical antibody-drug conjugate (ADC), which is currently in ...

PE: What impact will FDA's ANDA Prioritization Pilot have on efficiency and competitiveness? Botha: Setting up new ...

Biologic age is determined by measuring how well the body’s cells and organs are functioning. This is different than ...

CSL delayed the CSL Seqirus spin-off due to lower-than-expected US vaccination rates, affecting revenue growth and share ...

Shortly following the announcement of its acquisition of Syndivia’s ADC, GSK entered into a worldwide exclusive license ...

Obesity is a complex, treatable medical condition, not just a matter of willpower, requiring a shift in perception and ...

Novo Nordisk recently confirmed reports about its unsolicited proposal submission to Metsera, aimed at acquiring its early ...